These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7344094)

  • 1. IV. Labetalol in the management of severe hypertension.
    Ee B; Aw TC; Yeo PP; Teoh PC; Chia BL
    Singapore Med J; 1981 Oct; 22(5):295-7. PubMed ID: 7344094
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 6. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 13. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Labetalol--ergometric and polycardiographic studies].
    Dziekański S; Adamska-Dyniewska H; Słomka S; Tkaczewski W
    Wiad Lek; 1984 Mar; 37(5):334-41. PubMed ID: 6475046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of labetalol in essential hypertension. Effects of long-term treatment in conditions of rest and stress].
    Rossi A; Ziacchi V; Lomanto B
    Minerva Cardioangiol; 1980 Sep; 28(9):637-44. PubMed ID: 7007921
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 18. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
    Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
    Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.